301 related articles for article (PubMed ID: 9373448)
1. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause.
Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada-Charneco M; Lund del Castillo JD
Clin Endocrinol (Oxf); 1997 Sep; 47(3):279-85. PubMed ID: 9373448
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of bone mineral density in hyperthyroid patients before and after medical therapy].
Safi S; Hassikou H; Hadri L; Sbihi A; Kadiri A
Ann Endocrinol (Paris); 2006 Mar; 67(1):27-31. PubMed ID: 16596054
[TBL] [Abstract][Full Text] [Related]
3. Bone mass after long-term euthyroidism in former hyperthyroid women treated with (131)I influence of menopausal status.
Serraclara A; Jódar E; Sarabia F; Hawkins F
J Clin Densitom; 2001; 4(3):249-55. PubMed ID: 11740067
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?
Földes J; Tarján G; Szathmari M; Varga F; Krasznai I; Horvath C
Clin Endocrinol (Oxf); 1993 Nov; 39(5):521-7. PubMed ID: 8252739
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density trends in Indian patients with hyperthyroidism--effect of antithyroid therapy.
Dhanwal DK; Gupta N
J Assoc Physicians India; 2011 Sep; 59():561-2, 567. PubMed ID: 22334969
[TBL] [Abstract][Full Text] [Related]
6. TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy.
Siderova M; Hristozov K; Tsukeva A
Arch Endocrinol Metab; 2018; 62(2):221-226. PubMed ID: 29768627
[TBL] [Abstract][Full Text] [Related]
7. Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism.
Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada M; Luna JD; Olea N
J Clin Endocrinol Metab; 1997 Jun; 82(6):1989-94. PubMed ID: 9177418
[TBL] [Abstract][Full Text] [Related]
8. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
Ongphiphadhanakul B; Puavilai G; Rajatanavin R
J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
[TBL] [Abstract][Full Text] [Related]
9. [Bone mineral density of the femoral neck, a cross-sectional study of normal values in 827 French women aged 36 to 86 years].
Tsouderos Y; Bauza-Canellas C; Decassin P; Denis M; Cusset B; Audrain S
Rev Rhum Ed Fr; 1994 Jun; 61(6):439-46. PubMed ID: 7833869
[TBL] [Abstract][Full Text] [Related]
10. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease.
Lucidarme N; Ruiz JC; Czernichow P; Léger J
J Pediatr; 2000 Jul; 137(1):56-62. PubMed ID: 10891822
[TBL] [Abstract][Full Text] [Related]
11. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: role of biological markers of bone turnover.
Jódar Gimeno E; Muñoz-Torres M; Escobar-Jiménez F; Quesada Charneco M; Luna del Castillo JD; Oleà N
Calcif Tissue Int; 1997 Nov; 61(5):370-6. PubMed ID: 9351877
[TBL] [Abstract][Full Text] [Related]
12. Change in bone mineral density in patients with hyperthyroidism after attainment of euthyroidism by dual energy X-ray absorptiometry.
Wakasugi M; Wakao R; Tawata M; Gan N; Inoue M; Koizumi K; Onaya T
Thyroid; 1994; 4(2):179-82. PubMed ID: 7920000
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in male patients with L-thyroxine suppressive therapy and Graves disease.
Jódar E; Martínez-Díaz-Guerra G; Azriel S; Hawkins F
Calcif Tissue Int; 2001 Aug; 69(2):84-7. PubMed ID: 11683428
[TBL] [Abstract][Full Text] [Related]
14. A hospital based study of biochemical markers of bone turnovers & bone mineral density in north Indian women.
Kumar A; Devi SG; Mittal S; Shukla DK; Sharma S
Indian J Med Res; 2013 Jan; 137(1):48-56. PubMed ID: 23481051
[TBL] [Abstract][Full Text] [Related]
15. Thyrotoxic bone disease in women: a potentially reversible disorder.
Diamond T; Vine J; Smart R; Butler P
Ann Intern Med; 1994 Jan; 120(1):8-11. PubMed ID: 8250460
[TBL] [Abstract][Full Text] [Related]
16. Spine and femur BMD by DXA in patients with varying severity spinal osteoporosis.
Ryan PJ; Blake GM; Herd R; Parker J; Fogelman I
Calcif Tissue Int; 1993 Apr; 52(4):263-8. PubMed ID: 8467405
[TBL] [Abstract][Full Text] [Related]
17. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
Földes J; Lakatos P; Zsadányi J; Horváth C
Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
[TBL] [Abstract][Full Text] [Related]
18. Influence of basal energy expenditure and body composition on bone mineral density in postmenopausal women.
Quirino MA; Modesto-Filho J; de Lima Vale SH; Alves CX; Leite LD; Brandão-Neto J
Int J Gen Med; 2012; 5():909-15. PubMed ID: 23204854
[TBL] [Abstract][Full Text] [Related]
19. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
Rahim A; Holmes SJ; Adams JE; Shalet SM
Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density of the spine and femur in healthy Saudis.
Ardawi MS; Maimany AA; Bahksh TM; Nasrat HA; Milaat WA; Al-Raddadi RM
Osteoporos Int; 2005 Jan; 16(1):43-55. PubMed ID: 15167986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
